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ABSTRACT
Morquio syndrome is a rare lysosomal storage disease that affects multiple organ systems. However, it is rarely 
associated with malignancy. We present the case of a 30-year old man with Morquio syndrome associated with gastric 
adenocarcinoma. This case also demonstrates two other findings that have not been previously described in patients 
with Morquio syndrome - malrotation of brainstem and cerebellum, without clinical neurologic deficit, and persistence 
of fetal lobulation in the kidneys. 
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INTRODUCTION
Morqu io  syndrome i s  a  ra re  autosoma l 
recessive lysosomal storage disease referred to as 
mucopolysaccharidosis (MPS) type IV, which is further 
divided into IVA and IVB subtypes depending on the 
enzyme deficiency. Type IVA is caused by the deficiency 
of enzyme N-acetyl-galactosamine-6-sulfatase causing 
intracellular accumulation of keratan sulfate and 
chondroitin 6-sulfate whereas type IVB is caused by 
β-galactosidase deficiency causing accumulation of 
keratan sulfate only.1 Morquio patients can present 
with musculoskeletal abnormalities such as muscular 
atrophy, pectus carinatum, dysostosis multiplex, odontoid 
hypoplasia, short stature, dorsilumbar kyphoscoliosis 
and waddling gait. Atlantoaxial subluxation leading to 
spinal cord compression in the upper cervical region can 
be life threatening. This subluxation is a consequence of 
odontoid dysplasia, which is a major complication of MPS 
type IV.2 The manifestations that can develop later in the 
life include corneal opacity, deafness, hypermobility of 
joints, cardiac abnormalities, quadriplegia and respiratory 
paralysis.3 Morquio syndrome has rarely been associated 
with carcinomas or other malignancies. A search of the 
literature revealed only one case of osteosarcoma arising 
in the vicinity of hardware in the femur of an 18-year-
old man with Morquio syndrome.4 We present a case 
of metastatic gastric adenocarcinoma arising in a man 
with Morquio syndrome, which was diagnosed in early 
childhood and presented the typical findings of this 
syndrome at the end of life.
CASE REPORT
The patient was a 30-year-old African American 
man with Morquio syndrome diagnosed at age 3 by 
a constellation of physical findings and laboratory 
investigation. He had classic physical findings of 
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Morquio syndrome including coarse facial features, 
short stature, short neck, pectus carinatum, genu 
valgum and thoracic kyphosis. Radiographic studies 
also revealed findings consistent with Morquio 
syndrome. However, records of pertinent laboratory 
testing, such as increased urinary glycosaminoglycan 
levels or GALNS gene sequencing, were not available 
for review. The family history was significant for 
breast carcinoma in father, skin carcinoma in sister 
and esophageal carcinoma in paternal grandfather. 
He was diagnosed with poorly differentiated gastric 
adenocarcinoma at age 28 and was being treated 
with chemo and radiotherapy. The disease however 
persisted, and later the patient returned to the hospital 
complaining of back pain and shortness of breath. At 
the time of admission, the man was dyspneic with 
normal vital signs. Physical examination revealed a body 
mass index of 19, cachectic appearance, anasarca, 
pectus carinatum, genu valgum, short stature and 
thoracic kyphosis with exaggerated lumbar lordosis 
(Figure 1A, 1B and 1C). However, no neurological 
deficit was noted.
Laboratory studies were within normal limits except 
for anemia with hemoglobin of 8.5 gm/dL (normal range 
[NR]; 13.5 to 18.0 gm/dL) and leukopenia with a white 
blood cell count of 1700/mm3 [NR]; 4000-11000/mm3). 
Imaging studies revealed cardiomegaly, multifocal 
osseous metastatic disease (Figure 2), degenerative 
disc disease resulting in varying degrees of central 
canal and foraminal stenosis, wedge deformities of 
Figure 1. Thoracic CT Scan showing scoliosis of the thoracic spine (A, coronal plane) and 3D reconstruction showing 
thoracic scoliosis and kyphosis (B and C, coronal and sagittal planes).
Figure 2. Bone scintigraphy using 99mTc in anterior, posterior, right posterior oblique, and left anterior oblique 
views showing multifocal osseous metastatic disease.
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C2 and C4 without evidence of displaced fracture, 
chronic osseous changes of upper lumbar spine with 
significant vertebral body compression, bilateral hip 
disarticulations and small liver metastases.
His condition deteriorated during the course of 
hospitalization and on hospital day 10 he was found 
unresponsive in pulseless electrical activity and was 
unable to be resuscitated following 24 minutes of 
attempted resuscitation. He was pronounced dead and 
a postmortem examination was requested.
AUTOPSY FINDINGS
Significant findings at autopsy included poorly 
differentiated gastric adenocarcinoma (Figure 3A) 
metastatic to left supraorbital dura, pituitary gland, 
pericardium, lungs with evidence of lymphangitic 
carcinomatosis, liver, peripancreatic soft tissue, 
mesentery of large bowel, wall of colon, bilateral 
periadrenal soft tissue, thoracic vertebrae, periprostatic 
soft tissue and urinary bladder. Additionally, the 
pericardium, peritoneum, peripancreatic soft tissue, 
periadrenal soft tissue, perithyroidal soft tissue, 
laryngeal soft tissue, periprostatic soft tissue, 
small and large bowel and subdural soft tissue 
surrounding the spinal cord showed mucoid material 
containing distended cells with foamy cytoplasm and 
eccentric nuclei (Figure 3B and 3C), consistent with 
a mucopolysaccharidosis. Other notable findings 
at autopsy were persistence of fetal lobulation in 
each kidney, severe malrotation of brainstem and 
cerebellum (Figure 4A and 4B) and thinning of optic 
chiasma and left optic nerve.
Figure 3. Photomicrography of poorly differentiated gastric adenocarcinoma (A, H&E, 400X) and mucoid material 
consistent with mucopolysaccharide material (B and C, H&E, 200X and 400X respectively). Metastatic tumor in a 
background of mucoid material (D, H&E, 200x).
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Death was likely due to aggressive metastatic 
gastric adenocarcinoma, with skeletal complications 
of probable MSP IV – namely vertebral scoliosis and 
kyphosis as well as atlantoaxial instability - likely 
contributing to death, as well. The manner of death 
was natural.
DISCUSSION
Lysosomes are the key component of intracellular 
digestion. They contain hydrolytic enzymes which 
are secreted into intracellular organelles and catalyze 
the breakdown of complex macromolecules. With 
inherited deficiency of lysosomal enzymes, the 
catabolism of the macromolecules remains incomplete 
leading to accumulation of insoluble metabolite in 
the lysosomes. The lysosomes therefore become 
larger and interfere with normal cell function leading 
to “lysosomal storage diseases”.5 It is not just the 
enzyme deficiency but several other defects that lead 
to lysosomal storage diseases, including deficiency of 
enzyme activator, deficiency of substrate activating 
protein, and deficiency of transport protein facilitating 
exit of digested material from lysosome.6
MPS represent a subset of lysosomal storage diseases 
in which mucopolysaccharides / glycosaminoglycans 
(GAGs) accumulate in the lysosomes. GAGs include 
chondroitin-4-sulfate, chondroitin-6-sulfate, heparan 
sulfate, dermatan sulfate, keratan sulfate and 
hyaluronan. MPS are usually progressive diseases 
and involve multiple organ systems. Each type of 
MPS has a unique clinical presentation, however, 
most are associated with coarse facial features, 
corneal clouding, joint stiffness, skeletal deformities, 
hepatosplenomegaly, valvular lesions and lesions of 
the brain.
Morquio syndrome (MPS IV) has an incidence 
of 1 in 75,000.7 It is further divided into IVA and 
IVB subtypes depending on the enzyme deficiency. 
Type IVA is  caused by def ic iency of enzyme 
N-acetyl-galactosamine-6-sulfatase and type IVB 
is caused by β-galactosidase deficiency.1 Clinical 
presentation and other features of Morquio syndrome 
are summarized in Table 1.
Lysosomes play a vital role in biology of malignant 
cells. Their effect can be oncogenic or on the contrary 
may also be apoptotic.8 This occurs via complex molecular 
pathways involving cathepsins and other proteins. 
Regarding MPS associated with neoplasia, Gaucher 
disease is the disorder that has been studied most 
extensively. Carcinomas of breast, prostate, colon, lung, 
ovary, kidney, bladder, liver and thyroid, non-melanoma 
skin cancers, ganglioneuroma and neurosarcoma, 
angiosarcoma, testicular rhabdomyosarcoma and 
carcinoid tumor have all been reported in patients 
with Gaucher disease.9 Hematologic malignancies 
including multiple myeloma, Hodgkin and non-Hodgkin 
lymphoma, acute lymphoblastic and myeloid leukemias, 
and chronic lymphocytic leukemia have also been 
reported in patients with Gaucher disease.9 Gaucher 
disease, for example, confers a relative risk of 5.9 of 
developing multiple myeloma.9 Overall, though, with 
the exception of Gaucher disease, lysosomal storage 
diseases in general and MPS in particular are rarely 
associated with malignancy. This may be secondary 
to the decreased life expectancy of patients with 
many MPS, or to other factors which have yet to be 
understood through further investigation and research. 
Thorough search of literature revealed only rare cases of 
Figure 4. Macroscopic examination of brain revealed malrotation of cerebellum (A) and brainstem (B).
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other MPS associated with different malignancies, which 
are summarized in Table 2 and include the present case.
Our case showed aggressive metastatic gastric 
adenocarcinoma in a patient with likely MPS IV based 
on clinical physical and laboratory findings in the past 
and characteristic findings at postmortem examination. 
In 9 out of 11 metastatic sites, the metastatic 
adenocarcinoma was present in a background of mucoid 
material containing distended cells with foamy cytoplasm 
and eccentric nuclei consistent with likely underlying 
mucopolysaccharidosis (Figure 3D). This finding suggests 
a causal relationship at least between metastatic 
propensity of a tumor and MPS such as MPS IV. However 
the molecular mechanisms underlying such a potential 
relationship need to be elucidated to confirm such a 
relationship, if one exists at all.
Another notable finding in the current case 
was persistent fetal lobulation in the kidneys, which 
represent a normal variant reflecting incomplete fusion 
of the developing renal lobules. The kidney function 
is essentially normal, however, the ultra-sonographic 
findings in such kidneys may be mistaken as scars.13 
To our limited knowledge, this finding has not been 
described in patients with Morquio syndrome. Lastly, 
the brain examination of our case also demonstrated 
Table 1. Morquio Syndrome
MPS IVA MPS IVB
Gene involved GALNS GLB1
Chromosomal 
locus 16q24.3 3p22.3
Deficient enzyme Galactose-6-sulfate sulfatase β-galactosidase
Accumulated 
products
Keratan sulfate and
Keratan sulfate
Chondroitin 6-sulfate
Clinical 
presentation
Facial features: Frontal bossing and flat nasal bridge.
Skeletal abnormalities: IVA > IVB: Dysostosis multiplex, odontoid hypoplasia, short stature, pectus 
carinatum, scoliosis and waddling gait.
Late manifestations: Aortic valve disease especially in IVA, corneal opacity and deafness.
Table 2. Malignancies associated with Lysosomal storage diseases
Lysosomal storage disease Malignancy
Gaucher Disease 126 of 2742 patients had some kind of malignancy9
Gaucher Disease 9 of 403 patients with Type I Gaucher Disease had two or more malignancies10
Niemann-Pick Disease Liver cancer in a 65 year old patient11
MPS I Poorly differentiated ependymoma in a 19 month old12
Morquio Syndrome Osteosarcoma of right femur in an 18 year old man4
Morquio Syndrome Gastric adenocarcinoma [current case]
a severe malrotation of brainstem and cerebellum. 
However, the patient did not have any neurologic 
deficit in 30 years of life. It is highly likely that this 
malrotation was related to odontoid hypoplasia and 
could very well be a protective mechanism against 
brainstem and spinal cord compression, which is 
common complication of odontoid hypoplasia in 
Morquio patients.
CONCLUSION
Morquio syndrome is a well-known entity but 
our understanding of the disorder is still limited. 
This case elaborates a few new findings in patients 
with MPS IV. Take home messages from the case 
are: i) patients with Morquio syndrome may have 
persistence of fetal lobulations in kidneys, which should 
not necessarily be interpreted as renal scarring on 
ultrasound examinations; ii) neurologic abnormalities 
in MPS include structural brain abnormalities such as 
malrotation of brainstem and cerebellum and such 
findings can be asymptomatic; and iii) MPS may play 
a role in carcinogenesis and/or metastasis of epithelial 
neoplasms.
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